Verve Therapeutics, Inc. (VERV): A Bull Case Theory

We came across a bullish thesis on Verve Therapeutics, Inc. on Stock Region Research’s Substack by Stock Region. In this article, we will summarize the bulls’ thesis on VERV. Verve Therapeutics, Inc.'s share was trading at $11.26 as of June 26^th.

[caption id="attachment_1220844" align="aligncenter" width="768"] A scientist in a laboratory working on a gene editing tool, to create treatments for rare genetic diseases.[/caption]

Verve Therapeutics’ stock surged an astounding 75% following Eli Lilly’s $1.3 billion acquisition announcement, signaling a pivotal moment for the...